Rp Management, LLC Biocryst Pharmaceuticals Inc Transaction History
Rp Management, LLC
- $76.9 Million
- Q2 2024
A detailed history of Rp Management, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Rp Management, LLC holds 3,846,154 shares of BCRX stock, worth $30.8 Million. This represents 30.91% of its overall portfolio holdings.
Number of Shares
3,846,154
Previous 3,846,154
-0.0%
Holding current value
$30.8 Million
Previous $19.5 Million
21.66%
% of portfolio
30.91%
Previous 99.98%
Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
257Shares Held
173MCall Options Held
397KPut Options Held
444K-
Black Rock Inc. New York, NY20MShares$160 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.8MShares$150 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.6MShares$101 Million1.06% of portfolio
-
State Street Corp Boston, MA9.35MShares$74.9 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.83MShares$70.7 Million4.25% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.49B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...